Industry ownership intelligence

Medical Devices insider conviction

Executive and director activity assessed across 83 companies for breadth, transaction quality, clustering, freshness, and directional conviction.

Market dashboard Healthcare sector Company signals Filing ledger Data API

48/100

Balanced insider tape

90/100 confidence

Level: Industry
Evidence window: Latest 90 days
Named insiders: 642
Latest evidence: 7 Aug 2026

Capital positioning read

Balanced insider tape

Acquisition and disposal evidence is mixed after low-information compensation and derivative activity is separated out.

Wait for clearer clustering

Evidence in favour

126 distinct acquisition events survive duplicate and security-type controls.
Participation spans 642 named insiders rather than one filing source.
The latest qualifying evidence is fresh, dated 07 Aug 2026.

Decision risks

Qualifying disposal events outnumber acquisitions, although disposals receive a lower directional weight.

Conviction48Balanced insider tape

Confidence90Deep evidence

Controlled events489directional common-share events

Company breadth83represented companies

Acquisition value$26.8Mnormalized amount

Disposal value$270.7Mnormalized amount

Flow regime

Twelve-week filing pressure

Shows the cadence and balance of the full filing tape.

15825 May

30901 Jun

16008 Jun

15715 Jun

7922 Jun

11129 Jun

7006 Jul

4213 Jul

3420 Jul

8227 Jul

5303 Aug

010 Aug

AcquisitionsDisposalsScore 48 · Confidence 90

Relative positioning

Industry peer map

Current score with confidence.

Pharmaceutical RetailersConviction accumulation7216 confidence Medical DistributionAccumulation bias6667 confidence Drug Manufacturers - GeneralAccumulation bias5794 confidence BiotechnologyBalanced insider tape5291 confidence Medical DevicesBalanced insider tape4890 confidence Diagnostics & ResearchDistribution bias3895 confidence Medical Care FacilitiesDistribution bias3693 confidence Health Information ServicesDistribution bias3691 confidence Medical Instruments & SuppliesDistribution bias3691 confidence Drug Manufacturers - Specialty & GenericDistribution bias3594 confidence Healthcare PlansDistribution bias3492 confidence

Directional balance

Controlled event mix

25.8%acquisition

Acquisition events: 126
Disposal events: 363
Net value: -$243.9M

Accumulation

Constructive company clusters

RCELAvita Medical Ltd8868 conf.BSXBoston Scientific Corp8696 conf.TMCITreace Medical Concepts Inc8568 conf.ENOVEnovis Corp8364 conf.RPIDRapid Micro Biosystems Inc8061 conf.CTSOCytosorbents Crp7840 conf.TELATela Bio Inc7551 conf.STIMNeuronetics Inc7546 conf.

Distribution review

Disposal concentrations

CTKBCytek Biosciences Inc1270 conf.IRMDIradimed Co1272 conf.LUNGPulmonx Corp1277 conf.AVNSAvanos Medical Inc1282 conf.MDTMedtronic PLC1289 conf.MASS908 Devices Inc1291 conf.DXCMDexCom Inc1294 conf.BFLYButterfly Network Inc1297 conf.

Evidence density

Most active controlled tapes

STE29 controlled events27Concentrated distribution BFLY24 controlled events12Concentrated distribution SIBN20 controlled events34Distribution bias CTKB19 controlled events12Concentrated distribution IRMD17 controlled events12Concentrated distribution SYK16 controlled events12Concentrated distribution MASS16 controlled events12Concentrated distribution QTRX16 controlled events33Distribution bias

Evidence quality

What the filings represent

Common equity1021

Equity compensation301

Options and derivatives231

Other securities10

Decision makers

Role participation

Director886

Other executive252

CEO and chair145

Finance leadership115

Other or unspecified112

Large holder53

Quality controls

Evidence usability

Normalized values: 34%
Priced common share: 33%
Named insiders: 642
Controlled events: 489

Auditable evidence

Latest Medical Devices filings

Showing 901 to 930 of 1563.

3 Jun 2026

HYPRHyperfine Inc

WOLTERMAN, DANDirector

AcquisitionOptions and derivatives